Reverba CEO and Co-Founder Cheryl Lubbert Wins 2023 Silver Stevie® Award for Women in Business

– Awards recognize female entrepreneurs, executives and employees who are making positive contributions to their workplace and to the greater community – SEATTLE, WA, Nov. 13, 2023 – Reverba, a leading global patient engagement company, today announced that Cheryl Lubbert, Chief Executive Officer, has won the Silver Stevie® Award for Women in Business in the Mentor of the Year…

The Stevie Awards for Women in Business - Mentor or Coach of the Year - Cheryl Lubbert
,

|

– Awards recognize female entrepreneurs, executives and employees who are making positive contributions to their workplace and to the greater community –

SEATTLE, WA, Nov. 13, 2023 – Reverba, a leading global patient engagement company, today announced that Cheryl Lubbert, Chief Executive Officer, has won the Silver Stevie® Award for Women in Business in the Mentor of the Year category.

The Stevie® Awards for Women in Business recognize female entrepreneurs, executives and employees as well as the organizations they run. More than 1,500 entries were submitted this year for consideration in more than 100 categories. Finalists were determined by the average scores of more than 200 business professionals around the world.

“We’re proud that Cheryl Lubbert has been honored with a Stevie Award for Women in Business,” said Christina Hughes, COO of Reverba. “Cheryl is a pioneer in healthcare, helping amplify patient voices and creating patient engagement solutions for biopharmaceutical companies. Mentorship has played a key role in these efforts. While patients may turn to online resources for advice, they often seek the counsel of someone who has experienced the same medical journey. Reverba has made it a core mission to connect patients with these mentors while factoring in compliance and privacy.”

Reverba (formerly Health Perspectives Group) also received the 2016 Bronze Stevie® Award in the Company/Organization category as a Women owned business.

About the Stevie® Awards

Stevie Awards are conferred in eight programs: the Asia-Pacific Stevie Awards, the German Stevie Awards, The American Business Awards, The International Business Awards, the Middle East & North Africa Stevie Awards, the Stevie Awards for Women in Business, the Stevie Awards for Great Employers, and the Stevie Awards for Sales & Customer Service. Stevie Awards competitions receive more than 12,000 nominations each year from organizations in more than 70 nations. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at https://stevieawards.com/.

About Reverba

Reverba is a global patient engagement company that creates transformative tech-enabled solutions to build a bridge between patients and biopharmaceutical companies, from discovery to clinical development through commercialization.  Formed from the mergers of Health Advocacy Strategies, Patient Health Perspectives and Health Perspectives Group and rebranded as Reverba in 2021, the company consolidated its clinical and commercial divisions to provide comprehensive custom patient engagement solutions with its proprietary reverbaBRIDGE™ technology platform. Health Stories Project, a wholly owned subsidiary of Reverba, is a sharing community about personal health experiences, participation in clinical trials and other activities.  For more than 20 years, Reverba has incorporated compliance throughout its technology platforms and patient engagement solutions, maintaining SOC 2, Type II certification for the highest level of security. For more information, visit reverba.com or contact connect@reverba.com

The Latest

  • Perspective From Patients as Partners: Sustaining Patient Engagement Through Organizational Changes
    Perspective From Patients as Partners: Sustaining Patient Engagement Through Organizational Changes

    At Patients as Partners 2026, CEO Cheryl Lubbert shared how sustaining patient engagement through organizational change requires intentional design, with systems built to hold as teams, priorities, and programs shift.

  • Pharma USA 2026: AI Scales Reach in Pharma. But What Actually Changes Patient and HCP Behavior?
    Pharma USA 2026: AI Scales Reach in Pharma. But What Actually Changes Patient and HCP Behavior?

    AI is becoming a baseline expectation in pharma. At Pharma USA 2026, discussions reflected less focus on whether AI should be used and more on how it is being applied…

  • Approval Is Not the Finish Line: Turning Late-Stage Clinical Evidence Into Real-World Impact
    Approval Is Not the Finish Line: Turning Late-Stage Clinical Evidence Into Real-World Impact

    Late-stage clinical programs establish the evidence required for regulatory evaluation, but they do not guarantee adoption, access, or commercial performance. Translating that evidence into real-world impact requires patient-centered execution and…

See More Insights